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Abstract
Background and Objective: Transcranial low-level laser therapy (LLLT) using near-infrared light can efficiently penetrate
through the scalp and skull and could allow non-invasive treatment for traumatic brain injury (TBI). In the present study, we
compared the therapeutic effect using 810-nm wavelength laser light in continuous and pulsed wave modes in a mouse
model of TBI.
Study Design/Materials and Methods: TBI was induced by a controlled cortical-impact device and 4-hours post-TBI 1-group
received a sham treatment and 3-groups received a single exposure to transcranial LLLT, either continuous wave or pulsed
at 10-Hz or 100-Hz with a 50% duty cycle. An 810-nm Ga-Al-As diode laser delivered a spot with diameter of 1-cm onto the
injured head with a power density of 50-mW/cm2 for 12-minutes giving a fluence of 36-J/cm2. Neurological severity score
(NSS) and body weight were measured up to 4 weeks. Mice were sacrificed at 2, 15 and 28 days post-TBI and the lesion size
was histologically analyzed. The quantity of ATP production in the brain tissue was determined immediately after laser
irradiation. We examined the role of LLLT on the psychological state of the mice at 1 day and 4 weeks after TBI using tail
suspension test and forced swim test.
Results: The 810-nm laser pulsed at 10-Hz was the most effective judged by improvement in NSS and body weight although
the other laser regimens were also effective. The brain lesion volume of mice treated with 10-Hz pulsed-laser irradiation was
significantly lower than control group at 15-days and 4-weeks post-TBI. Moreover, we found an antidepressant effect of LLLT
at 4-weeks as shown by forced swim and tail suspension tests.
Conclusion: The therapeutic effect of LLLT for TBI with an 810-nm laser was more effective at 10-Hz pulse frequency than at
CW and 100-Hz. This finding may provide a new insight into biological mechanisms of LLLT.
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Introduction
Traumatic brain injury (TBI) and its sequelae affect at least 1.4
million people in the United States with an associated mortality of
50,000 and permanent disability of 90,000 each year [1,2]. The long-
term cognitive, psychosocial and physical deficits that follow TBI, lead
to an annual economic burden of about 60 billion dollars [3,4,5]. For
instance, the most frequent psychiatric manifestation seen following
TBI is depression, which may affect one-third or more of patients [6],
and these patients usually need a variety of long-term services, in-
cluding rehabilitative therapies, assistive technologies, and expensive
medical equipment. A growing number of studies have been carried
out for therapy of TBI, however there is no accepted effective treat-
ment so far and clinical trials of pharmaceuticals have generally failed.
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In recent times, low-level laser therapy (LLLT) has been
clinically applied for a range of medical indications. One of the
areas attracting increasing interest is the use of LLLT to treat
neurological diseases such as stroke, neurodegenerative diseases,
brain injury, and spinal cord injury [7,8,9,10,11,12]. The fact
there is no effective drug-based therapies for most of these
disorders has encouraged researchers to consider the use of laser
treatment. Since near-infrared laser can efficiently penetrate into
biological tissue including the central nervous system, producing
non-invasive beneficial photobiomodulation effects such as
promoting nerve regeneration and increasing ATP synthesis.
These effects can be attributed to a photochemical mechanism
based on light absorption by mitochondrial chromophores rather
than the production of heat [13,14,15,16].
The efficacy of LLLT on TBI has been previously investigated
to a limited extent. Oron et al. demonstrated that 808-nm Ga-As
laser irradiation for a mouse brain traumatized by a weight-drop
device promoted long-term restoration of neurological function
[17]. More recently, our studies have shown that both 665-nm and
810-nm laser can significantly improve the neurobehavioral
performance of mice after severe TBI, while 980-nm laser did
not produce the same positive effect [18]. On the other hand,
Lapchak et al. compared the neuroprotective effects of LLLT for
ischemic strokes in rabbits using 808-nm continuous wave (CW)
and pulsed laser [19,20]. The study demonstrated both 1000-Hz
and 100-Hz pulsed laser produced a similar effect on increase in
cortical ATP content superior to CW. Thus, some agreement has
emerged on the best wavelengths of laser for treatment of TBI,
however the effect of laser pulse frequencies on therapeutic
modulation for TBI remains unclear.
In the present study, we compared the therapeutic effect using
810-nm continuous wave and pulsed lasers on the neurological
and histological outcome of the traumatized mice.
Results
Transmitted Laser Power to the Brain Tissue
The measurement of laser power transmission was performed to
assess the extent to which transcutaneous and transcranial 810-nm
laser irradiation penetrates to the depth of the brain surface.
Figure 1 shows the relationship between incident and transmitted
laser power in continuous mode. The transmittances with different
frequencies (CW, pulsed wave (PW) 10 Hz and 100 Hz) are sum-
marized in Table 1. These results revealed that the transmitted
power did not depend on laser pulse frequency; 15% of the
incident laser power was transmitted through skin and 6% of that
incident power penetrated through skin and skull combined. In the
in vivo experiment the 810-nm laser was applied transcutaneously
(1-cm diameter spot), while the hole in the skull under the skin was
partially present (4 mm in diameter). Thus, the data showed that
approximately 3–7.5 mW/cm2 of irradiance would reach the
brain if the incident irradiance was 50 mW. The measurement of
the temperature increase in the brain tissue revealed that the
maximum temperature increase during laser irradiation was less
than 1uC.
Figure 1. Laser transmission through scalp and skull. Plot of measured incident laser power against measured transmitted laser power in CW
mode through mouse scalp and scalp and skull combined. Values are expressed as mean 6 S.D; n = 3.
doi:10.1371/journal.pone.0026212.g001
Table 1. Transmittance of laser power through ex vivo
mouse scalp and skull (average 6 SD, n = 3).
Transmittance (%) CW PW 10 Hz PW 100 Hz
Scalp 15.2561.18 14.3061.30 14.5461.78
Scalp and skull 6.2660.68 5.7660.75 5.9060.98
doi:10.1371/journal.pone.0026212.t001
Pulsed vs. CW Transcranial LLLT for TBI in Mice
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Improvement of neurological severity score (NSS)
Figure 2A shows the changes of NSS at different post-trauma
intervals. The initial severity of injury was similar in the four groups
of mice as reflected by the NSS at 1 h post-TBI; 7.7060.15 in the
control, 7.7060.37 in the CW, 7.7060.15 in the PW 10 Hz, and
7.5060.22 in the PW 100 Hz (all the groups, n=10). At 48 h after
TBI, there was a significant (P,0.01) decrease of NSS in the all
three laser treated groups that became even more pronounced
(P,0.001) as time progressed and lasted until the end of the study at
28 days. At day 7 it became clear that the improvement in the PW
10 Hz group was greater than that seen in the CW and PW 100 Hz
laser treated groups. In order to determine the statistical significance
difference between the various laser groups we integrated the NSS
for each mouse over the 28-day time course and compared the
means of the area under the curve (AUC) values between groups
(Figure 2B). The TBI group had a mean AUC that was significantly
higher than the treated groups (P,0.0001) and the AUC of the PW
10 Hz group was significantly lower than both the CW group
(p= 0,004) and the PW 100 Hz group (P= 0.0018). All groups of
mice continued to improve throughout the 28-day duration of the
study. The averages of NSS at 4 weeks post-TBI were 2.5060.27 in
the control TBI, 1.3060.21 in the CW, 0.6060.22 in the PW 10-
Hz, and 1.3060.26 in the PW 100-Hz laser-treated group,
respectively.
General health and antidepressant effects of laser
treatment
Figure 3 shows the changes of body weight measured at
different post-TBI time points. As compared with pre-injury levels,
body weight was decreased at days 1 and 2 post-injury in the all
traumatized mice, while the body weight of the sham-operated
mice (just with a craniotomy) was gradually increased. The body
weight of laser-treated mice recovered faster and reached a higher
level than that of the untreated-TBI mice. The time at which the
minimum in the body weight was recorded was 2 days post-TBI
in the laser-treated mice (CW; 0.88460.023, PW 10 Hz;
0.88060.017, and PW 100 Hz; 0.85460.024), although untreated
TBI mice continued to lose weight up to 5 days post-TBI
(0.83760.043). Body weight almost returned to pre-injury levels at
4 weeks after TBI and tended to continue to increase gradually.
The possible antidepressant effect of LLLT was investigated in
the forced swim and tail suspension- behavioral tests. In the forced
swim test, there was no significant difference of immobility
durations between the groups at 1 day after TBI as shown in
Figure 4A. However after 28 days the mice treated with the PW
10-Hz laser showed a significant decrease of immobility time
compared to the untreated TBI mice (Fig. 4B). In addition, the
immobility periods at 4 weeks post-injury were significantly shorter
than those at measured at 1 day after TBI in the all laser-treated
groups (CW, PW 10 Hz and 100 Hz), suggesting the antidepres-
sant activity of LLLT. Figure 5 shows the immobility times in the
tail suspension test. There was a significant decrease of the
immobility periods in the PW 10-Hz laser-treated mice relative to
the untreated TBI mice at 1 day post-injury (Fig. 5A). After 28
days, the immobility time significantly decreased in both the PW
10-Hz and the PW 100-Hz laser-treated groups as compared to
the untreated TBI mice (P,0.01). Moreover, there was a
significant difference between the CW and the PW 10-Hz laser-
treated mice at 4 weeks post-TBI (P,0.05).
ATP contents in the brain after laser
The ATP contents in the traumatized side of the mouse brain
were measured immediately after the laser irradiation at 4 h post-
TBI to investigate the effect of LLLT on enhancement of
mitochondrial function. Figure 6 shows the cortical ATP content
in mice brain tissue as a function of treatment groups. For
comparison, the ATP content of a normal mouse (not given TBI)
was measured. At 4 h post-injury, there was a moderate decrease
of ATP content within traumatized cortex as compared to the
same cortical region excised from native mice. In the normal mice,
baseline cortical ATP content was 21.162.9 nmol per mg protein,
compared to 15.861.1 nmol per mg protein in the untreated TBI
mice. The cortical ATP content in the CW and PW 100-Hz mode
LLLT treated mice were 18.162.1 and 16.163.2 nmol per mg
Figure 2. NSS scores after laser treatment. (A) Time course of neurological severity score (NSS) of mice with TBI receiving either control (no
laser-treatment), or 810-nm laser (36 J/cm2 delivered at 50 mW/cm2 with a spot size of 0.78 cm2) in either CW, PW 10 Hz or PW 100 Hz modes.
Results are expressed as mean 6 S.E.M (n = 10). *** P,0.001 vs. the other conditions. (B) Mean areas under the NSS-time curves in the two-
dimensional coordinate system over the 28-day study for the 4 groups of mice. Results are means 6 SD (n = 10).
doi:10.1371/journal.pone.0026212.g002
Pulsed vs. CW Transcranial LLLT for TBI in Mice
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protein respectively, while the PW 10-Hz laser treatment resulted
in 19.463.2 nmol per mg protein. However, the increases were
not statistically significantly different from ATP contents measured
in the control mice.
Decrease of lesion size in laser treated TBI
The histological assessments of the brain cross-sections removed
at 2, 15 and 28 days post-TBI of the untreated TBI mice and the
laser-treated mice are shown in Figure 7. Figure 8 shows the
quantitative analysis of lesion areas based on the histological
images. All mice demonstrated a steady increase in lesion size as
time progressed. This is expected as the natural history of TBI is
for progressive loss of brain tissue as the lesion progresses [21]. At
15 and 28 days after injury, the untreated TBI mice had a
significantly higher loss of cortical brain tissue around the
traumatized site compared to the PW 10-Hz laser-treated mice
(15 days post-TBI; P,0.05, 28 days post-TBI; P,0.01). On the
other hand, there was no significant difference between the
untreated TBI mice and those treated with other modes of laser at
any time point. The time course of the progression of cavitary
cortical lesions implied a neuroprotective effect of LLLT,
particularly at the early stages after TBI.
Discussion
In the present study, we compared the therapeutic effects using
an 810-nm diode laser at continuous wave and at two different
pulse frequencies as a non-invasive treatment of TBI in mice.
Karu et al. previously suggested that cytochrome c oxidase was
a primary photoacceptor when cells are irradiated with far red to
Figure 4. Forced swim test for depression. Immobility duration in forced swim test (FST) at (A) 1 day and (B) 28 days after brain injury and laser
irradiation. Values are in mean 6 S.E.M. (n = 10). { P,0.05 vs. values at 1 day after TBI. * P,0.05 between the groups.
doi:10.1371/journal.pone.0026212.g004
Figure 3. Body weight as a measure of health status. Variation of total body weight in healthy (sham control; n = 3), traumatic brain injury (TBI)
and 3 groups of 810-nm laser-treated mice (n = 10).
doi:10.1371/journal.pone.0026212.g003
Pulsed vs. CW Transcranial LLLT for TBI in Mice
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near infrared radiation [22]. More recent work has demonstrated
that light at both 670-nm and 830-nm can cause the upregulation
of cytochrome c oxidase in cultured primary neurons functionally
inactivated with potassium cyanide [23]. In other studies, Anders
et al. showed that noninvasive transcutaneous application of 810-
nm light to spinal cord injury in rats could cause a significant
increase in the number of regenerating corticospinal tract axons
and the length of axonal regrowth [11,12]. Our previous report on
LLLT for TBI showed that both red laser (665 nm) and near
infrared laser (810 nm) can significantly improve the neurobehav-
ioral performance of mice after closed head TBI [18]. Thus, we
selected the wavelength of 810 nm in this study to demonstrate the
potential therapeutic effect for TBI.
As shown in previous papers, laser power at a wavelength of
810 nm can efficiently penetrate through biological tissue
[8,9,11,24,25]. The most important parameter for the penetration
depth of laser in tissue is wavelength, however it is often claimed
that a pulsed laser can penetrate more deeply into tissue than CW
laser even with the same average power, due to increased
penetration of photons at the pulsed peak. Since the peak power
is expressed as average power divided by duty cycle, the peak
power with a pulsed mode is twice as high as the CW mode in this
work (PW; 100 mW/cm2, CW; 50 mW/cm2). The measurement
of the average penetrative power showed the irradiant power to
brain tissue was similar regardless of laser frequencies; 15% of the
laser power was transmitted through a skin and 6% of that
penetrated through a combination of skin and skull. Therefore, the
irradiant fluence to a brain was 2.2–5.4 J/cm2 since the total
fluence for skin was 36 J/cm2. The range was consistent with our
previous study in where cellular responses of primary cortical
neurons to an 810-nm-laser irradiation showed some positive
biomodulatory effects such as significant increase of calcium, ATP
and mitochondrial membrane potential (MMP) with a laser dose
of 3 J/cm2 [26]. In addition, the short period of laser irradia-
tion (12 min) was also reasonable in terms of possible clinical
application.
The fundamental mechanism of LLLT is proposed to involve
photons being absorbed by mitochondria leading to increased
cytochrome c oxidase activity [27], release of nitric oxide (NO)
[28] and an increase in ATP levels [29,30]. However, there is a
limited attention for the understanding of the pulsing effect on
neurological outcome although a recent review did find evidence
for the overall increased benefit of pulsed laser over CW laser [31].
The present work demonstrated that the changes of NSS and
changes in the antidepressant effect of LLLT were different
between the CW, PW 10-Hz and 100-Hz laser irradiation despite
the finding that the energy penetrating to the brain was the same.
The efficacy of LLLT for diverse neurological diseases including
stroke has been demonstrated in a number of animal and human
studies [9,17,19,32,33,34] and LLLT also has been shown to
improve emotional response and memory performance in middle-
aged CD-1 mice [35]. Depression following TBI or stroke is a
persistent problem that requires the close attention of medical and
rehabilitation professionals [6,36]. Although, the antidepressant
effect of LLLT has not been definitely investigated so far there is
one report of transcranial LED (single treatment with 810 nm)
improving major depression and anxiety in a 10-patient clinical
trial. The results of FST and TST demonstrated that laser
irradiation with a pulsed 10-Hz mode efficiently reduced the
immobility periods in TBI mice. LLLT could therefore ameliorate
Figure 6. ATP content in brain. Cortical ATP content in mice brain
tissue of left side (traumatic injury) immediately after laser treatment.
Values are in mean 6 S.E.M. (n = 5).
doi:10.1371/journal.pone.0026212.g006
Figure 5. Tail suspension test for depression and anxiety. Tail suspension test (TST) showing immobility periods out of 360 sec total test
duration carried out at (A) 1 day; and (B) 28 days after TBI and laser irradiation. Values are in mean 6 S.E.M. (n = 10). * P,0.05.
doi:10.1371/journal.pone.0026212.g005
Pulsed vs. CW Transcranial LLLT for TBI in Mice
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a symptom of depression that was possibly a long-term sequela
of TBI.
The histological images indicated the prevention of cell death
and the protection of neural cells from apoptosis or necrosis at the
early stage post-TBI (primary injury) by LLLT. These findings
were consistent with some previous reports suggesting LLLT
stimulated cell proliferation and inhibited induction of apoptosis
[27,37,38], while others have shown that too high fluences of light
could have deleterious effects on cells by inducing apoptosis via
generation of high levels of reactive oxygen species) [39,40].
Thus, the prevention of neuronal damage would explain the
observation that the body weight recovered earlier than the
untreated TBI mice and the reduction of cavitary cortical lesions.
If the primary injury is severe, it is known that the secondary
injury starts to occur about one week after TBI. For instance, some
studies showed neurodegeneration after head trauma could be
widespread during a period of days to months [41,42,43,44].
Secondary injury results from physiological disturbances caused by
the initial damage, and from the development of cerebral ischemia
and disruption of the blood-brain barrier [45,46]. Therefore, the
LLLT-induced prevention of cell death at the primary stage could
provide the long-term therapeutic effects.
There is some evidence that pulsed light (laser or LED) does
have effects that are different from those of continuous mode [31].
Previously, a wound healing study performed by Kymplova et al.
concluded a 670-nm laser pulsed at various frequencies (10, 25,
and 50 Hz) promoted wound repair more than the CW light
source [47]. In research on pain relief, Sushko et al. found that
both CW and PW modes of 670-nm laser delivery reduced the
behavioral manifestations of somatic pain as compared to the
controls, but the application of pulsed light (especially, at 10 and
8000 Hz) was more effective [48]. Moreover, some past studies
have shown particular pulsing frequencies appear to be more
efficacious than others in triggering desired biological processes
[19,20,49,50].
One possible reason why laser irradiation at 10-Hz pulsed mode
was most effective for improving neurological outcome is that the
hypothesis that the frequency affects the whole brain. Since the
brain has waves with specific frequencies, such as alpha waves,
beta waves and theta waves, there exists the possibility of
resonance occurring between the frequency of the pulsed light
and that of the brain waves. Particularly relevant is the fact that
oscillation of theta waves that have a prominent 4–10-Hz rhythm
in the hippocampal region of all mammals previously studied
[51,52,53]. The fact that the hippocampus is responsible for
behavioral inhibition and attention, spatial memory, and naviga-
tion suggests that the significant neurological recovery observed
with the PW 10-Hz laser treatment may possibly have resulted
from the positive resonance between the pulsing frequency of the
laser and the electrical activity of neurons in the hippocampus. In
fact, the hippocampus is one of the regions to suffer brain damage
in Alzheimer’s disease, and a recent study showed that transcranial
laser therapy using an 808-nm laser diode attenuated amyloid
plaque development in the transgenic mouse model with mutant
amyloid- precursor protein, implying the possible efficacy of this
Figure 7. Histology of brain slices. Histological images of cross-sections of brains from control non-laser-treated and laser-treated TBI mice
removed at day 28.
doi:10.1371/journal.pone.0026212.g007
Figure 8. Area of brain lesions. Results of quantitative analysis of
the area of cavitary cortical lesions in brain tissue on the basis of the
histological images. Values are means 6 S.E.M. (n = 9). * P,0.05.
doi:10.1371/journal.pone.0026212.g008
Pulsed vs. CW Transcranial LLLT for TBI in Mice
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therapeutic strategy for Alzheimer’s disease [54]. However, further
study is necessary to establish whether the resonance effect can
explain the superiority of pulsed laser. Another conceivable
mechanism for the superiority of pulsed laser over CW is the
idea that the pulse duration (100 msec) is similar to some
biological time period involved with cell stimulation by laser. This
time period could be for instance the half-life of an ion channel in
the mitochondrial membrane or some other membrane in the cell
that responds to light, one report gave a value of 160 ms [55].
In conclusion, transcranial LLLT with an 810-nm laser
improved neurobehavioral recovery in TBI, more effectively at
10-Hz pulsed mode than at CW or 100-Hz pulsed mode. Further
studies are necessary to define the detailed mechanisms behind this
observation, but the finding may provide novel insight into
biological mechanisms of LLLT. Clinical trials of transcranial
LLLT for patients who have suffered acute TBI should be
considered considering the likely clinical efficacy in stroke and the
apparent lack of possible side-effects.
Materials and Methods
Ethics statement
All animal experiments were approved by the Subcommittee on
Research Animal Care of the Massachusetts General Hospital
(protocol number 2009N000006) and were in accordance with the
guidelines of the National Institutes of Health (NIH).
Animal Preparation
Male BALB/c mice (weight 18 to 26 g; Charles River
Laboratories, Wilmington, MA) were used in this study. They
were housed in groups of 4–5 per cage, in a 12 h: 12 h light: dark
cycle. Food and water were provided ad libitem.
Laser power transmission through skin and skull
Preliminary experiments were carried out with fresh skin and
skull removed from sacrificed uninjured mice. Transmission of
laser power was determined using a laser power meter capable of
measuring pulsed irradiation (Ophir Nova II, North Logan, UT)
to measure the transmitted power, and the incident power density
using the specified surface irradiance of on the surface of the brain
was calculated to be 3–7.5 mW/cm2.
Traumatic Brain Injury Model
Mice were subjected to a single left lateral controlled cortical
impact (CCI) with craniotomy [56,57,58]. After mice were
anesthetized with isoflurane, the top of the skull was exposed with
a 1-cm skin incision in the scalp. A craniotomy was performed
over the left parietal cortex using a 4-mm trephine attached to an
electric drill. The angle of the drill and the head of the mouse were
adjusted so that the craniotomy penetrated the thin skull of the
mouse without damaging the dura. The 3-mm diameter tip of the
impact device (AMS 201, AmScien Instruments, Richmond, VA)
was positioned on the left front-parietal cortex and the tip centered
3.0 mm anterior to lambda and 2.5 mm left of midline within the
craniotomy. The zero depth position was determined by aligning
the tip of the impact device in the down position with the surface
of the dura. The depth of injury was set 2 mm using a screw-
mounted adjustment. The dwell and total time of the impact
device was 50 and 80 msec, respectively. A velocity from 4.2 to
4.9 m/sec was obtained using settings of 150 pounds per square
inch (psi) for high pressure and 30 psi for the low pressure when
a cylinder of compressed nitrogen (Airgas East, Salem, NH)
was connected via a regulator. Immediately after impact the
craniotomy hole was sealed with bone wax, the scalp incision was
closed with a suture and mice were allowed to recover on a heating
pad. At 1 hour post-TBI severity of injury was assessed by
neurological severity score (see below). Mice with scores of 7 or 8
were eligible for inclusion in the study, while mice with scores
higher or lower that this range were ineligible for inclusion and
were sacrificed. A group of control mice (sham-operated mice)
received surgery including a craniotomy but no TBI.
Laser Treatment
Laser treatment was performed 4 h post-TBI using a diode laser
of 810-nm wavelength and maximal power output of 3.5 W
(DioDent Micro 810, HOYA ConBio, Fremont, CA) equipped
with quartz-silica fiber. After mice were positioned on a plastic
plate and covered by an aluminum sheet with a 1-cm diameter
hole, the distal tip of the fiber optics was set for transcutaneous
laser irradiation onto the injured side of the head at a power
density of 50 mW/cm2. The duration of laser irradiation was
12 min, and the total fluence was 36 J/cm2. While the laser mode
was set on continuous wave (CW), 10-Hz and 100-Hz pulsed wave
(PW) (duty cycle; 50%), the same average power density and total
fluence were applied in order to compare the differences of
therapeutic effects given by the laser conditions. The complete
laser parameters are given in Table 2. Possible heating effect by
the laser irradiation was measured by a thermocouple needle-
probe of 1.0-mm diameter inserted into the irradiated area in a
depth of 3 mm.
Neurological Severity Score (NSS)
The general health of the mice was monitored for 28 days after
injury and the neurological severity score (NSS) was assessed at
1 h, and 1, 2, 3, 5, 7, 10, 14, 21, and 28 days. Body weight was
also measured at the same time points. The NSS used in the
present study is a modification of the original one reported on the
closed-head injury (CHI) model and has been used in a number of
studies [59,60]. The tests are based on the ability of mice to
perform 10 different tasks (Table 3) that evaluate the motor ability,
balancing, and alertness of the mouse. One point is given for
failing to perform each of the tasks, which means a normal and
uninjured mouse scores 0, while a score of 10 means likely death.
Table 2. List of laser parameters.
Parameter Value
Wavelength 810-nm (+/2 2-nm)
Spot size Diameter = 1 cm, area = 0.78 cm2
Average irradiance 50 mW/cm2
Total fluence 36 J/cm2
Average power 39 mW
Total energy 28 J
Illumination time 12 minutes
A. Pulse frequency 10 Hz
A. Pulse duration 50 msec
A. Peak irradiance 100 mW/cm2
B. Pulse frequency 100 Hz
B. Pulse duration 5 msec
B. Peak irradiance 100 mW/cm2
doi:10.1371/journal.pone.0026212.t002
Pulsed vs. CW Transcranial LLLT for TBI in Mice
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Forced Swim Test (FST)
Forced swimming-induced immobility in mice was carried out
as described by Porsolt et al. [61,62] and modified by Aley et al.
[63]. Mice were gently placed in a transparent cylinder (20 cm in
diameter) filled with water (23–25uC). Filling the cylinder to a
depth of 12 cm prevented mice from using their tails to support
themselves in water. A mouse was considered as immobile when
it remained in an upright position with only minimal paw
movements permitted to keep the head above water. Immobility
was sampled the predominant behavior over every 5 s during the
last 4 min of a 6-min test session [64].
Tail Suspension Test (TST)
The tail suspension test was conducted as previously described
[65,66]. The method is based on the observation that a mouse
suspended by the tail shows alternate periods of agitation and
immobility. Mice were securely fastened by the distal end of the
tail to a flat stick surface and suspended in a visually isolated. The
presence or absence of immobility, defined as the absence of limb
movement, was sampled over a 6-min test session.
ATP Measurement
ATP fluorometric assay kit (K354-100, BioVision, Mountain
View, CA) was used according to the manufacturer’s instructions
to measure the ATP contents in mouse brain immediately after
the laser irradiation at 4-h post-TBI. Briefly, brain tissue was
homogenized in 1-mL of cell lysis buffer, and a portion was lysed
in ATP assay buffer and centrifuged at 10,000 rpm for 15 min at
4uC to pellet insoluble materials. The supernatant was collected
and ATP assay mixture was added in a 96-well plate, then the
plate was incubated at room temperature for 30 minutes. The
fluorometric signals at an excitation wavelength of 535 nm and
emission wavelength of 587 nm was measured in SpectraMax M5
Multi-Mode Microplate Readers (Molecular Devices, Sunnyvale,
CA). The concentration of ATP was calculated using ATP
standard curve and expressed in nmol per mg protein. Protein
concentrations in all brain samples were determined using BCA
protein assay kit (Pierce, Rockford, IL).
Histological Evaluation
At 2, 15 and 28 days after TBI, mice were deeply anesthetized
and fixed by transcardial perfusion with phosphate-buffered saline
(PBS) followed by perfusion and immersion in 4% paraformalde-
hyde. After the brains were removed and further fixed overnight,
they were embedded in OCT compound (Sakura Finetek USA
Inc., Torrance, CA), frozen in liquid nitrogen, cut into 15-mm-
thick axial sections, and stained with hematoxylin and eosin (HE).
Cavity area was measured by calculation for the percentage of the
lesion area compared with the contralateral hemisphere area using
Image J (NIH, Bethesda, MD).
Statistical Analysis
Differences of neurological severity scores were evaluated by
two-way repeated analysis of variance (ANOVA) with Bonferroni’s
post hoc test. In a two-dimensional coordinate system, the area-
under-the-curve (AUC) data, which represent the time courses of
NSS in the various groups of mice, were calculated using
numerical integration [67]. Differences in the AUC between the
untreated TBI and the laser-treated groups and between different
laser-treated groups were compared for statistical significance
using one way ANOVA.
Comparisons between the different groups in the other
behavioral tests and the cavity measurement were performed
using two-way repeated ANOVA with Tukey’s post hoc test.
Statistical analysis in the measurement of ATP contents was
evaluated using one-way factorial ANOVA followed by Tukey’s
post hoc test. A value of P,0.05 was regarded as statistically
significant.
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